ENGLEWOOD, Colo., Jan. 17, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSEAmerican:AMPE) (the "Company") today released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive Officer, Mike Martino.
Read more at prnewswire.comAMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here